Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steatohepatitis Caused by Ingestible Alcohol”

340 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 340 results

Early research (Phase 1)WithdrawnNCT04395950
What this trial is testing

Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism

Who this might be right for
NASH (Nonalcoholic Steatohepatitis)NAFLD (Nonalcoholic Fatty Liver Disease)
Columbia University
Early research (Phase 1)Study completedNCT04142424
What this trial is testing

Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Who this might be right for
Metabolic DisordersNon-alcoholic Steatohepatitis
AstraZeneca 73
Testing effectiveness (Phase 2)UnknownNCT05821010
What this trial is testing

Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic SteatohepatitisNon-Alcoholic Fatty Liver DiseaseFecal Microbiota Transplantation+6 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 48
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Not applicableStudy completedNCT03432377
What this trial is testing

Coffee Consumption and NASH in the French Population.

Who this might be right for
Non Alcoholic Steatohepatitis
Versailles Hospital 107
Testing effectiveness (Phase 2)Ended earlyNCT04378010
What this trial is testing

A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH

Who this might be right for
Non-Alcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 98
Testing effectiveness (Phase 2)Study completedNCT02126306
What this trial is testing

Beta Glucosylceramide for Treatment of NASH

Who this might be right for
Compliance Behavior
Hadassah Medical Organization 23
Testing effectiveness (Phase 2)Study completedNCT06104319
What this trial is testing

Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 61
Post-approval studies (Phase 4)Study completedNCT04639414
What this trial is testing

Combined Active Treatment in Type 2 Diabetes With NASH

Who this might be right for
Type 2 DiabetesNon-alcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver Disease (NAFLD)
German Diabetes Center 192
Not applicableStudy completedNCT03184376
What this trial is testing

Histological Improvement of NASH With Prebiotic

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Calgary 14
Large-scale testing (Phase 3)WithdrawnNCT01384578
What this trial is testing

Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India
Testing effectiveness (Phase 2)Study completedNCT03656068
What this trial is testing

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFatty LiverFibrosis, Liver+1 more
Pinnacle Clinical Research, PLLC 21
Testing effectiveness (Phase 2)Study completedNCT03517540
What this trial is testing

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 193
Testing effectiveness (Phase 2)Study completedNCT02912260
What this trial is testing

Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 125
Early research (Phase 1)Study completedNCT04091061
What this trial is testing

Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Pfizer 24
Large-scale testing (Phase 3)Study completedNCT01051219
What this trial is testing

Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

Who this might be right for
Nonalcoholic Steatohepatitis
Newcastle-upon-Tyne Hospitals NHS Trust 45
Testing effectiveness (Phase 2)Looking for participantsNCT03884075
What this trial is testing

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Who this might be right for
Non-Alcoholic SteatohepatitisNon-Alcoholic Fatty Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 104
Not applicableStudy completedNCT03590626
What this trial is testing

Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver DiseaseType2 Diabetes Mellitus
Medanta, The Medicity, India 60
Testing effectiveness (Phase 2)Study completedNCT01766713
What this trial is testing

Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
University of California, San Diego 50
Next Page